Assessment of Overpayment for Topical Dermatological Drugs-Clawbacks.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 31596427.
- Also identified by DOI 10.1001/jamadermatol.2019.3078 and PMC identifier 6802052.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study investigates the prevalence and cost of overpayments for topical dermatologic prescription drugs.